Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 7 results for "centrum broking"

IPO market in FY18: 5 stocks which more than doubled investors#39; wealth since listing
Money Control

IPO market in FY18: 5 stocks which more than doubled investors...

In FY18, 38 IPOs have concluded with IPO fundraising volume of above Rs 77,000 crore, Centrum Broking said in a report. Money Control, 1 day ago

1 images for "centrum broking"

MSN India, 6 months ago

Don’t short this market now, wait for confirmation; next target 10800: Centrum Broking

The roller-coaster move of Friday’ session has resulted in a formation of ‘Dragonfly Doji’ candle on the daily chart, says Jay Purohit of Centrum Broking
 Money Control2 months ago

PSU banks on Nifty see worst monthly fall in 2 years

The combined market capitalisation of the 21 listed PSU banks declined by about Rs 76,000 crore to Rs 425,800 crore during February. With shares of public-sector banks continuing to reel under pressure on Wednesday, the Nifty PSU Bank index posted its sharpest monthly fall in two years.   The Nifty PSU Bank index, the largest loser among sectoral indices, has slipped 16.4 per cent in February. The index fell 2.7 per cent to 2,975 in intra-day trade on Wednesday, but recovered to close ...
 Rediff.com3 weeks ago

Nifty likely to find stability in this week; 3 stocks which could give up to 15% return

After a volatile move in last few weeks amid Union Budget and the global market sell-off; we may see some stability in the market in coming days, Jay Purohit, Technical Derivatives Analyst at Centrum Broking Limited said in an interview.
 Money Control3 weeks ago

Aurbindo Pharma ranks 2nd among Indian's pharma cos

With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore recorded by Lupin but behind Sun Pharma, which reported Rs 19,350 crore sales. P V Ramaprasad Reddy, co-founder of Aurbindo Pharma, is known for his ability to learn along the way.   Some years ago he moved to the US to build business in new segments such as injectables, controlled substance and nutraceuticals. This has now helped the firm move up the value chain in formulations ...
 Rediff.com1 month ago

Small midcap could correct further by over 3-5%; 3 stocks with 11% return potential

At the current juncture, there is no sign of reversal seen in mid small cap indices and thus we may see a further correction of around 3-5% in coming days, Jay Purohit, Technical Derivatives Analyst, Centrum Broking Limited, said in an exclusive interview ...
 Money Control1 month ago

Equities Remain a Preferred Asset Class for Long-Term Wealth Creation

Payal Pandya Here are a few recommendations to help grow your wealth in 2018: Can Fin Homes Ltd Can Fin Homes is promoted by Canara Bank and is a niche player in the affordable housing finance segment. The company has consistently posted robust growth. It is ...
 The Financial Chronicle2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less